{"disease":{"id":"plasma-cell-dyscrasia","name":"plasma cell dyscrasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03616483","title":"The Indiana Myeloma Registry","phase":"","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT04210791","title":"Autologous Stem Cell Transplantation for Patients With AL Amyloidosis","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"Nanjing University School of Medicine","has_results":false},{"nct_id":"NCT07365059","title":"Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Qi deng","has_results":false},{"nct_id":"NCT05362331","title":"Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of California, San Francisco","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}